Literature DB >> 15876261

Imatinib in pregnancy.

Salam AlKindi, David Dennison, Anil Pathare.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15876261     DOI: 10.1111/j.1600-0609.2005.00420.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


× No keyword cloud information.
  6 in total

Review 1.  Pregnancies in patients with chronic myeloid leukemia in the era of imatinib.

Authors:  Liang-Piu Koh; Devendra Kanagalingam
Journal:  Int J Hematol       Date:  2006-12       Impact factor: 2.490

Review 2.  Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia.

Authors:  A K Fielding; G A Zakout
Journal:  Curr Hematol Malig Rep       Date:  2013-06       Impact factor: 3.952

Review 3.  A benefit-risk assessment of imatinib in chronic myeloid leukaemia and gastrointestinal stromal tumours.

Authors:  Dominik Wolf; Holger Rumpold
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

4.  Medical treatment of mammary desmoid-type fibromatosis: which benefit?

Authors:  Louise Scheer; Massimo Lodi; Sébastien Molière; Jean-Emmanuel Kurtz; Carole Mathelin
Journal:  World J Surg Oncol       Date:  2017-04-18       Impact factor: 2.754

Review 5.  Outcome of 3 pregnancies in a patient with chronic myeloid leukemia who received 3 types of tyrosine kinase inhibitors each in different pregnancy: follow-up of the case with a review of published reports.

Authors:  Hussain Alizadeh; Hassan Jaafar; Béla Kajtár
Journal:  Ann Saudi Med       Date:  2015 Nov-Dec       Impact factor: 1.526

6.  Two successful pregnancies in a woman with chronic myeloid leukemia exposed to nilotinib during the first trimester of her second pregnancy: case study.

Authors:  Monika Conchon; Sabri S Sanabani; Israel Bendit; Fernanda Maria Santos; Mariana Serpa; Pedro Enrique Dorliac-Llacer
Journal:  J Hematol Oncol       Date:  2009-10-06       Impact factor: 17.388

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.